Portal Vein Stenosis Management in the Long-Term After Living Donor Liver Transplant.

IF 0.7 4区 医学 Q4 TRANSPLANTATION
Konstantin Semash, Timur Dzhanbekov, Azimjon Usmonov
{"title":"Portal Vein Stenosis Management in the Long-Term After Living Donor Liver Transplant.","authors":"Konstantin Semash, Timur Dzhanbekov, Azimjon Usmonov","doi":"10.6002/ect.2025.0027","DOIUrl":null,"url":null,"abstract":"<p><strong>Objectives: </strong>Portal vein stenosis occasionally occurs as a postoperative complication of a living donor liver transplant. Portal vein stenosis decreases the portal venous blood supply to the liver graft and increases extrahepatic portal venous pressure, which may lead to liver dysfunction, splenomegaly, gastrointestinal bleeding, cytopenia, and ascites.</p><p><strong>Materials and methods: </strong>From November 2021 to February 2024, we treated 6 patients at our center who presented with clinical features of bilirubinemia and signs of portal hypertension (cytopenia, ascites) that occurred in the long-term after liver transplant. In all cases, portal vein stenosis was diagnosed by ultrasonography and contrast-enhanced computed tomography. The results of endovascular interventions on the portal vein were assessed.</p><p><strong>Results: </strong>All patients were treated with percutaneous transhepatic correction of portal vein stenosis with balloon venoplasty. In all cases, an ultrasonography guided percutaneous approach to the portal vein was performed. Balloon venoplasty was performed in all cases, and no stents were used. No postoperative complications occurred. Signs of portal hypertension and graft dysfunction regressed after an average of 1 month of observation. There were no recurrences during 15 months of follow-up.</p><p><strong>Conclusions: </strong>Our case series highlighted the importance of considering portal vein stenosis in the differential diagnosis of late-onset portal hypertension or liver graft dysfunction symptoms following liver transplant. The optimal treatment method is endovascular intervention.</p>","PeriodicalId":50467,"journal":{"name":"Experimental and Clinical Transplantation","volume":"23 5","pages":"347-353"},"PeriodicalIF":0.7000,"publicationDate":"2025-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Experimental and Clinical Transplantation","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.6002/ect.2025.0027","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"TRANSPLANTATION","Score":null,"Total":0}
引用次数: 0

Abstract

Objectives: Portal vein stenosis occasionally occurs as a postoperative complication of a living donor liver transplant. Portal vein stenosis decreases the portal venous blood supply to the liver graft and increases extrahepatic portal venous pressure, which may lead to liver dysfunction, splenomegaly, gastrointestinal bleeding, cytopenia, and ascites.

Materials and methods: From November 2021 to February 2024, we treated 6 patients at our center who presented with clinical features of bilirubinemia and signs of portal hypertension (cytopenia, ascites) that occurred in the long-term after liver transplant. In all cases, portal vein stenosis was diagnosed by ultrasonography and contrast-enhanced computed tomography. The results of endovascular interventions on the portal vein were assessed.

Results: All patients were treated with percutaneous transhepatic correction of portal vein stenosis with balloon venoplasty. In all cases, an ultrasonography guided percutaneous approach to the portal vein was performed. Balloon venoplasty was performed in all cases, and no stents were used. No postoperative complications occurred. Signs of portal hypertension and graft dysfunction regressed after an average of 1 month of observation. There were no recurrences during 15 months of follow-up.

Conclusions: Our case series highlighted the importance of considering portal vein stenosis in the differential diagnosis of late-onset portal hypertension or liver graft dysfunction symptoms following liver transplant. The optimal treatment method is endovascular intervention.

活体肝移植术后门静脉狭窄的长期处理。
目的:门静脉狭窄偶尔会作为活体肝移植术后并发症发生。门静脉狭窄使移植物门静脉供血减少,肝外门静脉压力升高,可导致肝功能障碍、脾肿大、胃肠道出血、细胞减少、腹水。材料与方法:自2021年11月至2024年2月,我中心收治了6例肝移植术后长期出现胆红素血症及门静脉高压症(细胞减少、腹水)征像的患者。在所有病例中,门静脉狭窄均通过超声检查和增强计算机断层扫描诊断。评估门静脉血管内介入治疗的效果。结果:所有患者均行经皮经肝门静脉球囊成形术矫治门静脉狭窄。在所有病例中,超声引导下经皮进入门静脉。所有病例均行球囊静脉成形术,未使用支架。无术后并发症发生。门静脉高压症和移植物功能障碍的症状在平均观察1个月后消退。随访15个月无复发。结论:我们的病例系列强调了在肝移植后迟发性门脉高压或肝移植功能障碍症状的鉴别诊断中考虑门静脉狭窄的重要性。最佳的治疗方法是血管内介入治疗。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
1.40
自引率
11.10%
发文量
258
审稿时长
6-12 weeks
期刊介绍: The scope of the journal includes the following: Surgical techniques, innovations, and novelties; Immunobiology and immunosuppression; Clinical results; Complications; Infection; Malignancies; Organ donation; Organ and tissue procurement and preservation; Sociological and ethical issues; Xenotransplantation.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信